Lipids Play a Key Role in the Pathogenesis of Multiple Sclerosis
Lipids, which play a key role in the pathogenesis of multiple sclerosis, can be used as targets or carriers of treatment.
MS Insights
New Perspectives on Diagnosing Multiple Sclerosis
A majority of the time, the diagnosis of progressive multiple sclerosis (MS) is retrospective, despite better drugs to counteract the progression of the disease in patients who are diagnosed early. In MS and other rare diseases that are not supported by scientific consensus confirming their etiology, physicians have often opted for a “wait-and-see” approach to…
New Studies: Multiple Sclerosis Patients Need Social Support
Due to the complex and unpredictable nature of multiple sclerosis (MS), health care providers should address the psychological and emotional needs of their patients with MS, according to a study published in the Journal of Neurology. The emotional issues that patients with MS experience are often overlooked, according to a survey of over 3000 MS…
Proteomics and Multiple Sclerosis: Where Do We Stand?
The wish for reliable biomarkers is particularly evident in diseases clinically silent in the early stages, as seems to be the case in multiple sclerosis (MS). In fact, in a recent study published in Neurology, Gasperi et al concluded that “patients with MS are frequently not diagnosed at their first demyelinating event but often years later.…
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...